Literature DB >> 22453247

Development of a neuromuscular electrical stimulation protocol for sprint training.

David W Russ1, Brian C Clark, Jodi Krause, Fredrick C Hagerman.   

Abstract

PURPOSE: Sprint training is associated with several beneficial adaptations in skeletal muscle, including an enhancement of sarcoplasmic reticulum (SR) Ca(2+) release. Unfortunately, several patient populations (e.g., the elderly, those with cardiac dysfunction) that might derive great benefit from sprint exercise are unlikely to tolerate it. The purpose of this report was to describe the development of a tolerable neuromuscular electrical stimulation (NMES) protocol that induces skeletal muscle adaptations similar to those observed with sprint training.
METHODS: Our NMES protocol was modeled after a published sprint exercise protocol and used a novel electrode configuration and stimulation sequence to provide adequate training stimulus while maintaining subject tolerance. Nine young, healthy subjects (four men) began and completed the training protocol of the knee extensor muscles.
RESULTS: All subjects completed the protocol, with ratings of discomfort far less than those reported in studies of traditional NMES. Training induced significant increases in SR Ca(2+) release and citrate synthase activity (~16% and 32%, respectively), but SR Ca(2+) uptake did not change. The percentage of myosin heavy chain IIx isoform was decreased significantly after training. At the whole muscle level, neither central activation nor maximum voluntary isometric contraction force were significantly altered, although isometric force did exhibit a trend toward an increase (~3%, P = 0.055). Surprisingly, the NMES training produced a significant increase in muscle cross-sectional area (~3%, P = 0.04).
CONCLUSIONS: It seems that an appropriately designed NMES protocol can mimic many of the benefits of sprint exercise training, with a low overall time commitment and training volume. These findings suggest that NMES has the potential to bring the benefits of sprint exercise to individuals who are unable to tolerate traditional sprint training.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453247     DOI: 10.1249/MSS.0b013e31825423f1

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  6 in total

1.  Reduced Neural Excitability and Activation Contribute to Clinically Meaningful Weakness in Older Adults.

Authors:  Leatha A Clark; Todd M Manini; Nathan P Wages; Janet E Simon; David W Russ; Brian C Clark
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-03-31       Impact factor: 6.053

2.  Is impaired dopaminergic function associated with mobility capacity in older adults?

Authors:  Simon Moskowitz; David W Russ; Leatha A Clark; Nathan P Wages; Dustin R Grooms; Adam J Woods; Julie Suhr; Janet E Simon; Andrew O'Shea; Cody R Criss; Paolo Fadda; Brian C Clark
Journal:  Geroscience       Date:  2020-11-24       Impact factor: 7.713

3.  Effect of Anodal Transcranial Direct Current Stimulation of the Motor Cortex on Elbow Flexor Muscle Strength in the Very Old.

Authors:  Kentaro Oki; Leatha A Clark; Shinichi Amano; Brian C Clark
Journal:  J Geriatr Phys Ther       Date:  2019 Oct/Dec       Impact factor: 3.381

4.  Heterogeneity of the strength response to progressive resistance exercise training in older adults: Contributions of muscle contractility.

Authors:  Leatha A Clark; David W Russ; Dallin Tavoian; W David Arnold; Timothy D Law; Christopher R France; Brian C Clark
Journal:  Exp Gerontol       Date:  2021-06-04       Impact factor: 4.253

5.  Voluntary vs Electrically Stimulated Activation in Age-Related Muscle Weakness.

Authors:  Brian C Clark; Todd M Manini; Nathan P Wages; Janet E Simon; Leatha A Clark
Journal:  JAMA Netw Open       Date:  2019-09-04

6.  Insights into the combination of neuromuscular electrical stimulation and motor imagery in a training-based approach.

Authors:  Amandine Bouguetoch; Alain Martin; Sidney Grosprêtre
Journal:  Eur J Appl Physiol       Date:  2021-01-08       Impact factor: 3.078

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.